TTD | Drug: D0V1EJ

Drug General Information
Drug ID	D0V1EJ
Former ID	DNC012632
Drug Name	6-(2-Dipropylamino-ethyl)-biphenyl-2,3,4'-triol
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[533481]
Structure		Download 2D MOL 3D MOL
Formula	C20H27NO3
Canonical SMILES	CCCN(CCC)CCC1=C(C(=C(C=C1)O)O)C2=CC=C(C=C2)O
InChI	1S/C20H27NO3/c1-3-12-21(13-4-2)14-11-16-7-10-18(23)20(24)19(16)15-5-8-17(22)9-6-15/h5-10,22-24H,3-4,11-14H2,1-2H3
InChIKey	NTNWFRQRDDNMJY-UHFFFAOYSA-N
PubChem Compound ID	13678327
Target and Pathway
Target(s)	Dopamine D1 receptor	Target Info	Inhibitor	[533481]
KEGG Pathway	Calcium signaling pathway
	cAMP signaling pathway
	Neuroactive ligand-receptor interaction
	Gap junction
	Dopaminergic synapse
	Parkinson's disease
	Cocaine addiction
	Amphetamine addiction
	Morphine addiction
	Alcoholism
PANTHER Pathway	Dopamine receptor mediated signaling pathway
PathWhiz Pathway	Dopamine Activation of Neurological Reward System
Reactome	Dopamine receptors
Reactome	G alpha (s) signalling events
WikiPathways	Hypothetical Network for Drug Addiction
	Monoamine GPCRs
	GPCRs, Class A Rhodopsin-like
	Genes and (Common) Pathways Underlying Drug Addiction
	GPCR ligand binding
	GPCR downstream signaling
References
Ref 533481	J Med Chem. 1986 Oct;29(10):1904-12.Synthesis and dopaminergic binding of 2-aryldopamine analogues: phenethylamines, 3-benzazepines, and 9-(aminomethyl)fluorenes.
Ref 533481	J Med Chem. 1986 Oct;29(10):1904-12.Synthesis and dopaminergic binding of 2-aryldopamine analogues: phenethylamines, 3-benzazepines, and 9-(aminomethyl)fluorenes.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information